{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:15:17Z","timestamp":1794003317642,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (TB) stigma may be a barrier to engagement in testing and treatment for TB infection (TBI). We systematically reviewed the available evidence on how TB stigma influences engagement with TBI testing and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic databases (e.g., CINAHL, Central, OVID) were searched from 1963 to 1st August 2024. Quantitative, qualitative, and mixed-method studies reporting the effects of TB stigma on engagement with TBI testing and treatment were included in the review. Descriptive synthesis was applied to the quantitative studies, and thematic analysis was applied to qualitative studies. The risk of bias was assessed by using the mixed methods appraisal tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen studies were included in the review (12 qualitative, four quantitative and one mixed methods). TB stigma was complex and multifactorial with six overlapping domains: public, anticipated, self, experienced, secondary, and structural. Perceptions or experiences of stigma were associated with lower rates of engagement in testing and adherence to treatment in TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Perceptions of TB stigma among people with TBI were related to the common social representation of TB disease such as its being contagious or disease of the poor. Negative perceptions of active TB appear to carry over to its infection, despite people being informed about the nature of TBI. Our findings could inform more effective communication to support TBI testing and treatment engagement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-024-20868-0","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T16:35:16Z","timestamp":1739550916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A systematic review exploring the role of tuberculosis stigma on test and treatment uptake for tuberculosis infection"],"prefix":"10.1186","volume":"25","author":[{"given":"Ay\u015fenur","family":"K\u0131l\u0131\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhash","family":"Jhuree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molebogeng X.","family":"Rangaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"20868_CR1","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using Mathematical Modelling. PLOS Med. 2016;13:e1002152.","journal-title":"PLOS Med"},{"key":"20868_CR2","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4:e20.","journal-title":"Lancet Microbe"},{"key":"20868_CR3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","volume":"386","author":"MX Rangaka","year":"2015","unstructured":"Rangaka MX, Cavalcante SC, Marais BJ, et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386:2344\u201353.","journal-title":"Lancet"},{"key":"20868_CR4","doi-asserted-by":"crossref","unstructured":"Loutet MG, Burman M, Jayasekera N, Trathen D, Dart S, Kunst H, et al. National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area. European Respiratory J. 2018;51(1).","DOI":"10.1183\/13993003.01226-2017"},{"key":"20868_CR5","unstructured":"World Health Organisation. WHO urges investments for the scale up of tuberculosis screening and preventive treatment. https:\/\/www.who.int\/news\/item\/18-03-2024-who-urges-investments-for-the-scale-up-of-tuberculosis-screening-and-preventive-treatment (accessed June 3, 2024)."},{"key":"20868_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269\u201378.","journal-title":"Lancet Infect Dis"},{"key":"20868_CR7","unstructured":"Global Fund. Fighting pandemics and building a healthier and more equitable world: global fund strategy 2023\u20132028. 2021."},{"key":"20868_CR8","unstructured":"Goffman E. Stigma: notes on the management of spoiled identity. Simon and schuster; 2009."},{"key":"20868_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/13548500600595053","volume":"11","author":"MG Weiss","year":"2006","unstructured":"Weiss MG, Ramakrishna J, Somma D. Health-related stigma: rethinking concepts and interventions. Psychol Health Med. 2006;11:277\u201387.","journal-title":"Psychol Health Med"},{"key":"20868_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12889-020-10055-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Du L, Wu R, et al. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health. 2021;21:6.","journal-title":"BMC Public Health"},{"key":"20868_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/00333549101250S407","volume":"125","author":"A Courtwright","year":"2010","unstructured":"Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125:34.","journal-title":"Public Health Rep"},{"key":"20868_CR12","unstructured":"Craig G, Meershoek A, Zwerling A et al. TB Stigma\u2013Measurement Guidance. 2018."},{"key":"20868_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1472-6963-9-169","volume":"9","author":"W Xu","year":"2009","unstructured":"Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9:169.","journal-title":"BMC Health Serv Res"},{"key":"20868_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09697-z","volume":"20","author":"I Spruijt","year":"2020","unstructured":"Spruijt I, Haile DT, van den Hof S, et al. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among eritreans in the Netherlands. BMC Public Health. 2020;20:1\u20139.","journal-title":"BMC Public Health"},{"key":"20868_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0002-9343(97)00467-1","volume":"102","author":"NH Miller","year":"1997","unstructured":"Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43\u20139.","journal-title":"Am J Med"},{"key":"20868_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2016.10.011","volume":"56","author":"GM Craig","year":"2017","unstructured":"Craig GM, Daftary A, Engel N, O\u2019Driscoll S, Ioannaki A. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. Int J Infect Dis. 2017;56:90\u2013100.","journal-title":"Int J Infect Dis"},{"key":"20868_CR17","doi-asserted-by":"publisher","first-page":"e0000989","DOI":"10.1371\/journal.pgph.0000989","volume":"2","author":"I Foster","year":"2022","unstructured":"Foster I, Galloway M, Human W, et al. Analysing interventions designed to reduce tuberculosis-related stigma: a scoping review. PLOS Glob Public Health. 2022;2:e0000989.","journal-title":"PLOS Glob Public Health"},{"key":"20868_CR18","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184"},{"key":"20868_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","volume":"39","author":"K Knobloch","year":"2011","unstructured":"Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Cranio-Maxillofac Surg. 2011;39:91\u20132.","journal-title":"J Cranio-Maxillofac Surg"},{"key":"20868_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/XEB.0000000000000282","volume":"19","author":"C Stern","year":"2021","unstructured":"Stern C, Lizarondo L, Carrier J, et al. Methodological guidance for the conduct of mixed methods systematic reviews. JBI Evid Implement. 2021;19:120\u20139.","journal-title":"JBI Evid Implement"},{"key":"20868_CR21","unstructured":"The EndNote Team. EndNote. 2013."},{"key":"20868_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.","journal-title":"Syst Rev"},{"key":"20868_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276\u201382.","journal-title":"Biochem Med"},{"key":"20868_CR24","unstructured":"Lumivero NV. 2017. www.lumivero.com"},{"key":"20868_CR25","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic analysis. American Psychological Association; 2012.","DOI":"10.1037\/13620-004"},{"key":"20868_CR26","first-page":"285","volume":"34","author":"QN Hong","year":"2018","unstructured":"Hong QN, F\u00e0bregues S, Bartlett G, et al. The mixed methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018;34:285\u201391.","journal-title":"Educ Inf"},{"key":"20868_CR27","unstructured":"World Bank Country and Lending Groups \u2013 World Bank Data Help Desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups (accessed Aug 8, 2024)."},{"key":"20868_CR28","unstructured":"Organization WH. WHO global lists of high burden countries for tuberculosis (TB). TBHIV Multidrugrifampicin-Resist TB MDRRR-TB 2021; 2025: 2021."},{"key":"20868_CR29","first-page":"263","volume":"9","author":"K Rowe","year":"2005","unstructured":"Rowe K, Makhubele B, Hargreaves J, Porter J, Hausler H, Pronyk P. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis. 2005;9:263\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"20868_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/B:JOIH.0000019166.80968.70","volume":"6","author":"J Coreil","year":"2004","unstructured":"Coreil J, Lauzardo M, Heurtelou M. Cultural feasibility assessment of Tuberculosis prevention among persons of Haitian origin in South Florida. J Immigr Health. 2004;6:63\u20139.","journal-title":"J Immigr Health"},{"key":"20868_CR31","doi-asserted-by":"crossref","unstructured":"Gao J, Berry NS, Taylor D, Venners SA, Cook VJ, Mayhew M. Knowledge and perceptions of latent tuberculosis infection among Chinese immigrants in a Canadian urban centre. Int J Fam Med 2015; 2015.","DOI":"10.1155\/2015\/546042"},{"key":"20868_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12879-022-07333-2","volume":"22","author":"GI Benoit V\u00e1squez","year":"2022","unstructured":"Benoit V\u00e1squez GI, Morrobel AL, Benjumea-Bedoya D, del Corral-Londo\u00f1o H. Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic. BMC Infect Dis. 2022;22:359.","journal-title":"BMC Infect Dis"},{"key":"20868_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/09540121.2017.1283390","volume":"29","author":"KB Jacobson","year":"2017","unstructured":"Jacobson KB, Niccolai L, Mtungwa N, Moll AP, Shenoi SV. It\u2019s about my life: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017;29:936\u201342.","journal-title":"AIDS Care"},{"key":"20868_CR34","doi-asserted-by":"publisher","first-page":"e0254211","DOI":"10.1371\/journal.pone.0254211","volume":"16","author":"RR Nathavitharana","year":"2021","unstructured":"Nathavitharana RR, van der Westhuizen A, van der Westhuizen H-M, et al. If I\u2019ve got latent TB, I would like to get rid of it: derivation of the CARD (constraints, actions, risks, and desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment. PLoS ONE. 2021;16:e0254211.","journal-title":"PLoS ONE"},{"key":"20868_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/pha.13.0010","volume":"3","author":"D Skinner","year":"2013","unstructured":"Skinner D, Hesseling A, Francis C, Mandalakas A. It\u2019s hard work, but it\u2019s worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3:191\u20138.","journal-title":"Public Health Action"},{"key":"20868_CR36","unstructured":"Williams D. An ethnography: Burmese refugees and Latent Tuberculosis Infection. 2015."},{"key":"20868_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/1753-6405.13021","volume":"44","author":"J Hall","year":"2020","unstructured":"Hall J, Kabir TM, Shih P, Degeling C. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants. Aust N Z J Public Health. 2020;44:353\u20139.","journal-title":"Aust N Z J Public Health"},{"key":"20868_CR38","doi-asserted-by":"publisher","first-page":"e108261","DOI":"10.1371\/journal.pone.0108261","volume":"9","author":"F Seedat","year":"2014","unstructured":"Seedat F, Hargreaves S, Friedland JS. Engaging new migrants in infectious disease screening: a qualitative semi-structured interview study of UK migrant community health-care leads. PLoS ONE. 2014;9:e108261.","journal-title":"PLoS ONE"},{"key":"20868_CR39","doi-asserted-by":"publisher","first-page":"e0000017","DOI":"10.1371\/journal.pgph.0000017","volume":"1","author":"A Heyd","year":"2021","unstructured":"Heyd A, Heffernan C, Storey K, Wild TC, Long R. Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: a qualitative descriptive study. PLOS Glob Public Health. 2021;1:e0000017.","journal-title":"PLOS Glob Public Health"},{"key":"20868_CR40","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.5588\/ijtld.17.0030","volume":"21","author":"N Sommerland","year":"2017","unstructured":"Sommerland N, Wouters E, Masquillier C, et al. Stigma as a barrier to the use of occupational health units for tuberculosis services in South Africa. Int J Tuberc Lung Dis. 2017;21:S75\u201380.","journal-title":"Int J Tuberc Lung Dis"},{"key":"20868_CR41","doi-asserted-by":"publisher","first-page":"e0243713","DOI":"10.1371\/journal.pone.0243713","volume":"15","author":"AW Kay","year":"2020","unstructured":"Kay AW, Thivalapill N, Skinner D, et al. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV. PLoS ONE. 2020;15:e0243713.","journal-title":"PLoS ONE"},{"key":"20868_CR42","doi-asserted-by":"publisher","first-page":"e43972","DOI":"10.2196\/43972","volume":"9","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jin J, Bi X, Geng H, Li S, Zhou C. Gender-Specific Association between Perceived Stigma toward Tuberculosis and Acceptance of Preventive Treatment among College Students with latent tuberculosis Infection: cross-sectional analysis. JMIR Public Health Surveill. 2023;9:e43972.","journal-title":"JMIR Public Health Surveill"},{"key":"20868_CR43","doi-asserted-by":"publisher","first-page":"e18435","DOI":"10.1371\/journal.pone.0018435","volume":"6","author":"DA Gust","year":"2011","unstructured":"Gust DA, Mosimaneotsile B, Mathebula U, et al. Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana. PLoS ONE. 2011;6:e18435.","journal-title":"PLoS ONE"},{"key":"20868_CR44","unstructured":"Pekovic V. Assessment of patient compliance in a tuberculosis preventive therapy trial in dually (HIV\/TB)-infected individuals in Uganda. Case Western Reserve University (Health Sciences); 1996."},{"key":"20868_CR45","unstructured":"Leventhal H, Benyamini Y, Brownlee S, et al. Illness representations: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of Health and Illness. Psychology; 1997."},{"key":"20868_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1742395310369018","volume":"6","author":"R Horne","year":"2010","unstructured":"Horne R, Clatworthy J, Hankins M, Investigators ASCOT. High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn. 2010;6:243\u201351.","journal-title":"Chronic Illn"},{"key":"20868_CR47","unstructured":"Horne R, Moon Z. Adherence to medication and treatment protocols. In: SAGE Textbook of Health Psychology. (In press)."},{"key":"20868_CR48","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization; 2018."},{"key":"20868_CR49","doi-asserted-by":"crossref","unstructured":"Aghaei A, Sakhaei A, Khalilimeybodi A, Qiao S, Li X. Impact of mass media on HIV\/AIDS stigma reduction: a systematic review and meta-analysis. AIDS and Behavior. 2023;27(10):3414\u201329.","DOI":"10.1007\/s10461-023-04057-5"},{"key":"20868_CR50","doi-asserted-by":"publisher","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients\u2019 adherence-related beliefs about Medicines prescribed for long-term conditions: a Meta-Analytic Review of the necessity-concerns Framework. PLoS ONE. 2013;8:e80633.","journal-title":"PLoS ONE"},{"key":"20868_CR51","unstructured":"The National Institute for Health and Care Excellence (NICE). Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. 2009 https:\/\/www.nice.org.uk\/guidance\/cg76\/resources"},{"key":"20868_CR52","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1186\/s12889-020-09053-1","volume":"20","author":"PF Rebeiro","year":"2020","unstructured":"Rebeiro PF, Cohen MJ, Ewing HM, et al. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health. 2020;20:897.","journal-title":"BMC Public Health"},{"key":"20868_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0001-6918(85)90039-3","volume":"59","author":"I Rock","year":"1985","unstructured":"Rock I. Perception and knowledge. Acta Psychol (Amst). 1985;59:3\u201322.","journal-title":"Acta Psychol (Amst)"},{"key":"20868_CR54","doi-asserted-by":"publisher","unstructured":"Horne R, Cooper V, Wileman V, Chan A. Supporting adherence to medicines for long-term conditions: A perceptions and practicalities approach based on an extended common-sense model. European Psychologist. 2019;24(1):82\u201396. https:\/\/doi.org\/10.1027\/1016-9040\/a000353.","DOI":"10.1027\/1016-9040\/a000353"},{"key":"20868_CR55","doi-asserted-by":"publisher","first-page":"1800485","DOI":"10.1183\/13993003.00485-2018","volume":"52","author":"MA Mes","year":"2018","unstructured":"Mes MA, Katzer CB, Chan AHY, Wileman V, Taylor SJC, Horne R. Pharmacists and medication adherence in asthma: a systematic review and meta-analysis. Eur Respir J. 2018;52:1800485.","journal-title":"Eur Respir J"},{"key":"20868_CR56","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/ecco-jcc\/jjz034","volume":"14","author":"S Chapman","year":"2020","unstructured":"Chapman S, Sibelli A, St-Clair Jones A, Forbes A, Chater A, Horne R. Personalised adherence support for maintenance treatment of inflammatory bowel disease: a tailored Digital intervention to change adherence-related beliefs and barriers. J Crohns Colitis. 2020;14:1394\u2013404.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-20868-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T16:35:26Z","timestamp":1739550926000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-20868-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20868"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-20868-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"628"}}